Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
92%
Tourette Syndrome
64%
Deep Brain Stimulation
59%
Movement Disorders
48%
Motor Symptoms
36%
Home Video
32%
Subacute Encephalopathy
32%
Interactive Mobile Application
32%
Baseline Data
32%
Research Consortium
32%
Interictal Epileptiform Discharges
32%
Receptor-interacting Protein Kinase 1 (RIPK1)
32%
Clinical Value
32%
Alcoholic
32%
Randomized Controlled Clinical Trial
32%
Aztreonam
32%
Seizure
32%
Design Information
32%
PASADENA
32%
Pharmacological Therapy
32%
Amyloid Precursor Protein
32%
Cerebellar Ataxia
32%
Natural History Study
32%
Early Parkinson's Disease
32%
Surgical Treatment
32%
Behavioral Symptoms
32%
Behavioral Therapy
32%
Behavioral Treatment
32%
Clinical Research
32%
Phase II Study
32%
Neurotoxicity
32%
Pimavanserin
32%
Current Management
32%
New-onset Refractory Status Epilepticus (NORSE)
32%
Neurite Outgrowth
32%
Hereditary Ataxia
21%
Standard of Care
20%
Nave
20%
Mobile Application
20%
Alpha-synuclein (α-syn)
18%
Cannabis Products
16%
Type II Inhibitor
16%
Ziprasidone
16%
Target Selection
16%
Comorbidity
16%
Disease Score
16%
Neurodegenerative Diseases
16%
Experimental Therapeutics
16%
Behavioral Comorbidities
16%
Alpha Agonist
16%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Gilles De La Tourette Syndrome
64%
Tic
48%
Pimavanserin
32%
Neurotoxicity
32%
Controlled Clinical Trial
32%
Aztreonam
32%
Prasinezumab
32%
Cerebellar Ataxia
32%
Clinical Research
32%
Biological Marker
32%
Hereditary Ataxia
21%
Side Effect
16%
Diseases
16%
Brain Disease
16%
Beta Lactam Antibiotic
16%
Beta Lactam
16%
Iatrogenic Disease
16%
Carbidopa Plus Levodopa
16%
Antiparkinson Agent
16%
Clinical Trial
14%
Disease Exacerbation
13%
Monoamine Oxidase B Inhibitor
11%
Motor Dysfunction
11%
Ataxia
10%
Comorbidity
10%
Spinocerebellar Degeneration
10%
Placebo
9%
4 Aminobutyric Acid Receptor
8%
Bullous Pemphigoid
8%
Acute Kidney Failure
8%
Drug Toxicity
8%
Cystitis
8%
Catechol
8%
Skin Disease
8%
Rosacea
8%
Synuclein
8%
Dopamine Receptor Stimulating Agent
8%
Dermatological Agent
8%
Rotigotine
8%
Apomorphine
8%
Amantadine
8%
Drug Discovery
8%
Methyltransferase Inhibitor
8%
Seborrheic Dermatitis
8%
Melanoma
8%
Alpha Synuclein
5%
Ziprasidone
5%
Fibroblast Growth Factor 14
5%
Aripiprazole
5%
Neuroscience
Tourette Syndrome
64%
Parkinson's Disease
35%
Amyloid Precursor Protein
32%
Pimavanserin
32%
Receptor
32%
Neurite Outgrowth
32%
Brain Disease
32%
Prasinezumab
32%
Behavioral Therapy
32%
Status Epilepticus
32%
Ataxia
32%
Comorbidity
32%
Side Effect
19%
Ziprasidone
16%
Aripiprazole
16%
Topiramate
16%
Clostridium Botulinum Type A
16%
Alpha-Adrenergic Agonist
16%
Monoamine
16%
Attention Deficit Hyperactivity Disorder
16%
Drug Therapy
16%
Receptor Antagonist
16%
Fluphenazine
16%
Risperidone
16%
Tardive Dyskinesia
16%
Transcranial Magnetic Stimulation
16%
Deep Brain Stimulation
16%
Obsessive-Compulsive Disorder
16%
Cannabis
16%
Lipoprotein Receptor-Related Protein
12%
Stereotypic Movement Disorder
11%
Monoamine Oxidase B
11%
Placebo
9%
Alpha-Synuclein
5%
Diffusion MRI
5%
Cerebellum
5%
Spinocerebellar Ataxia
5%
